NCT06368414
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
- Locations
-
- Gachon University Gil Medical Center Incheon, South Korea
Clinical trial condition
Chronic Myeloid Leukemia, Chronic Phase
Explore clinical trials studying Chronic Myeloid Leukemia, Chronic Phase. Study availability and eligibility vary by location and protocol.
16 public trials
5 recruiting studies
Chronic Myeloid Leukemia, Chronic Phase trial results
NCT06163430
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
- Locations
-
- University of Alabama Medicine (UAB Medicine) Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- UC Irvine Health Orange, California, United States
- Rocky Mountain Cancer Centers, LLP Lone Tree, Colorado, United States
NCT06409936
- Conditions
- Bone Marrow Diseases, CML, Chronic Phase, Chronic Disease, +15 more
- Locations
-
- Hospital del Mar (Barcelona) Barcelona, Spain
- Hospital Universitario Basurto Bilbao, Spain
- Institut Català d'Oncologia Girona Girona, Spain
- Hospital Virgen de las Nieves Granada, Spain
NCT06119269
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
- Locations
-
- University of Cagliari - Businco Hospital - Unit of Hematology and Bone Marrow Transplant Cagliari, Italy
- Policlinico Milano Milan, Italy
- University of Naples Federico II - Unit of Hematology Naples, Italy
- Santa Chiara University Hospital Pisa, Italy
NCT03459534
- Conditions
- Bone Marrow Diseases, CML - Philadelphia Chromosome, CML, Chronic Phase, +15 more
- Locations
-
- Territorial State Budgetary Institution Barnaul, Russia
- Federal State Budgetary Institution of Science Kirov, Russia
- Federal State Budgetary Institution Moscow, Russia
- Hematology Centre based on City Clin. Hosp. n.a. S.P. Botkin Moscow, Russia
Active, not recruiting
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
NCT05143840
- Conditions
- Adult CML, Bone Marrow Diseases, Chronic Disease, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Winship Cancer Institute Emory University Atlanta, Georgia, United States
- Georgia Cancer Center at Augusta University Augusta, Georgia, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
Active, not recruiting
Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
NCT03610971
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +13 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory -Winship Cancer Institute Atlanta, Georgia, United States
- Memorial Sloan Kettering - Bergen Montvale, New Jersey, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
Active, not recruiting
Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)
NCT04160546
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
- Locations
-
- Institut Català D'Oncologia L'Hospitalet (ICO) L'Hospitalet de Llobregat, Barcelona, Spain
- Hospital General Universitario Gregorio Marañón Madrid, Spain
- Hospital Ramón y Cajal Madrid, Spain
- Hospital Universitario y Politécnico La Fe Valencia, Spain
Active, not recruiting
Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia
NCT04147533
- Conditions
- Bone Marrow Diseases, Chemically-Induced Disorders, Chronic Disease, +17 more
- Locations
-
- University Hospital Brno Brno, Czechia
- University Hospital Hradec Kralove Hradec Králové, Czechia
- University Hospital Olomouc Olomouc, Czechia
- University Hospital Ostrava Ostrava, Czechia
Active, not recruiting
Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)
NCT03722420
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
- Locations
-
- Peking University People's Hospital(北京大学人民医院) Beijing, China